JANSSEN PRODUCTS, LP

Janssen Products, LP specializes in the manufacturing of pharmaceutical preparations, with a focused expertise in the production and supply of specialized therapeutics, including bedaquiline (SIRTURO) for the treatment of multidrug-resistant tuberculosis. The contractor demonstrates deep technical proficiency in aseptic manufacturing, drug formulation, and regulatory-compliant production processes aligned with FDA and cGMP standards. Their ability to deliver time-sensitive, high-purity pharmaceuticals under emergency and routine procurement channels highlights operational agility and stringent quality control capabilities. Key differentiators include consistent supply chain reliability for niche, life-critical medications and precise adherence to NDC-specific labeling and packaging requirements. The contractor maintains a sustained and exclusive relationship with the Department of Veterans Affairs, consistently supporting its pharmaceutical procurement needs through direct contracts and blanket purchase agreements. Their work centers on supplying critical antitubercular agents and other specialty drugs to VA medical facilities, ensuring uninterrupted access to therapies for veteran populations with complex health conditions. This long-standing partnership reflects a trusted supplier relationship built on reliability, regulatory compliance, and responsive fulfillment. Janssen Products, LP operates exclusively within NAICS 325412, Pharmaceutical Preparation Manufacturing, positioning itself as a niche manufacturer of specialty pharmaceuticals rather than a broad-spectrum producer. The company’s market focus is on high-complexity, low-volume drugs requiring controlled environments and specialized handling, serving the unique demands of federal healthcare systems. As a 2L entity headquartered in Horsham, Pennsylvania, Janssen Products, LP is structured as a corporate subsidiary with no federal certifications on record. Its geographic presence is centralized, with operations aligned to serve federal healthcare procurement networks through direct manufacturing and distribution channels. The company’s market positioning is defined by precision, compliance, and reliability in the delivery of critical pharmaceuticals to government health agencies.